Literature DB >> 3765601

Antihypertensive therapy, serum lipids, coronary heart disease and hypertension--balancing the risks and benefits of treatment.

M C Houston.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3765601      PMCID: PMC1306878     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  27 in total

1.  Treatment of mild hypertension: results of a ten-year intervention trial.

Authors:  W M Smith
Journal:  Circ Res       Date:  1977-05       Impact factor: 17.367

2.  The effect of oral hydralazine on circulating human cholesterol.

Authors:  H M PERRY; E J MILLS
Journal:  Am J Med Sci       Date:  1962-05       Impact factor: 2.378

3.  A primary preventive study of Gothenburg, Sweden.

Authors:  L Wilhelmsen; G Tibblin; L Werkö
Journal:  Prev Med       Date:  1972-03       Impact factor: 4.018

4.  Optimal dose of a thiazide diuretic.

Authors:  S Carney; A I Gillies; T Morgan
Journal:  Med J Aust       Date:  1976-10-30       Impact factor: 7.738

5.  Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: a double-blind controlled trial.

Authors:  R H Grimm; A S Leon; D B Hunninghake; K Lenz; P Hannan; H Blackburn
Journal:  Ann Intern Med       Date:  1981-01       Impact factor: 25.391

6.  Prazosin and clonidine for moderately severe hypertension.

Authors:  W M Kirkendall; J J Hammond; J C Thomas; M L Overturf; A Zama
Journal:  JAMA       Date:  1978-12-01       Impact factor: 56.272

7.  Antihypertensive therapy and the risk of coronary heart disease.

Authors:  R P Ames; P Hill
Journal:  J Cardiovasc Pharmacol       Date:  1982       Impact factor: 3.105

8.  Effect of prazosin on serum lipids.

Authors:  T Kokubu; I Itoh; H Kurita; T Ochi; K Murata; I Yuba
Journal:  J Cardiovasc Pharmacol       Date:  1982       Impact factor: 3.105

9.  Treatment of mild hypertension: a five year controlled drug trial. The Oslo study.

Authors:  A Helgeland
Journal:  Am J Med       Date:  1980-11       Impact factor: 4.965

10.  Oxprenolol, methyldopa and lipids in diabetes mellitus.

Authors:  G F Benfield; K R Hunter
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.